Skip to main content
Caplight Logo









Rundo Pharmaceutical R&D

Rundo Pharmaceutical R&D

Private
ShanghaiHealthcare & Life Scienceshttps://www.rundo-cro.com/

Last Round

Series C

May 6, 2019

Total Funding Raised

$14.85M

Company Overview

Rundo Pharmaceutical R&D (Shanghai) Co., Ltd. is a contract research organization (CRO) that provides one-stop clinical trial management services for pharmaceutical and biotech companies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CROcontract research organizationclinical research outsourcingclinical trial managementSMOpharma R&D servicessite management organizationclinical data managementbiostatisticsdrug development outsourcingregulatory affairsICH-GCP complianceNMPA filingeClinical solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rundo Pharmaceutical R&D Comparables

Compare Rundo Pharmaceutical R&D with similar companies based on industry and business-model similarity.

Rundo Pharmaceutical R&D comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
R&G PharmaStudies Co., Ltd.
84%
Hangzhou Tigermed Consulting Co., Ltd.
83%
Beijing CTSmed Co., Ltd.
81%

Rundo Pharmaceutical R&D Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 6, 2019
Series BMay 1, 2017
Series AMar 1, 2012
AngelMar 1, 2007

Rundo Pharmaceutical R&D Investors

Notable investors and investment history

Rundo Pharmaceutical R&D investors
InvestorRounds
HighLight CapitalSeries B
Welight CapitalSeries C
Sunshine Riverhead Capital Investment Management Co., Ltd.Series C
Gaozheng CapitalSeries A
Shenzhen Capital GroupSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2012

    Raised Series A with Shenzhen Capital Group and Gaozheng Capital.

Rundo Pharmaceutical R&D Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rundo Pharmaceutical R&D Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rundo Pharmaceutical R&D's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range44
Year Founded2004
Last FundingMay 6, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?